United States Epilepsy Drugs Sales Market Report 2021

August 2016 | 123 pages | ID: U97B3C88864EN
QYResearch

Abstracts

This report studies sales (consumption) of Epilepsy Drugs in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Eisai
• GSK
• Pfizer
• UCB
• AbbVie
• Acorda Therapeutics
• Alexza Pharmaceuticals
• Aprecia Pharmaceuticals
• Aurobindo Pharma
• Biscayne Pharmaceuticals
• CURx Pharmaceuticals
• Dainippon Sumitomo Pharma
• D-Pharm
• F. Hoffmann-La Roche
• Grupo Ferrer Internacional
• GW Pharmaceuticals
• Insero Health
• INSYS Therapeutics
• Janssen Pharmaceuticals
• Ligand Pharmaceuticals
• H. Lundbeck
• MarcoPolo Pharmaceuticals
• Marinus Pharmaceuticals
• Meda
• Neurelis
• Nobelpharma
• Novartis
• Orphelia Pharma
• SAGE Therapeutics
• SciFlour

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• First-generation Anti-epileptic Drugs
• Second-generation Anti-epileptic Drugs
• Third-generation Anti-epileptic Drugs

Split by applications, this report focuses on sales, market share and growth rate of Epilepsy Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Epilepsy Drugs Sales Market Report 2021

1 EPILEPSY DRUGS OVERVIEW

1.1 Product Overview and Scope of Epilepsy Drugs
1.2 Classification of Epilepsy Drugs
  1.2.1 First-generation Anti-epileptic Drugs
  1.2.2 Second-generation Anti-epileptic Drugs
  1.2.3 Third-generation Anti-epileptic Drugs
1.3 Applications of Epilepsy Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size (Value and Volume) of Epilepsy Drugs (2011-2021)
  1.4.1 USA Epilepsy Drugs Sales, Revenue and Price (2011-2021)
  1.4.2 USA Epilepsy Drugs Sales and Growth Rate (2011-2021)
  1.4.3 USA Epilepsy Drugs Revenue and Growth Rate (2011-2021)

2 USA EPILEPSY DRUGS COMPETITION BY MANUFACTURERS

2.1 USA Epilepsy Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Epilepsy Drugs Revenue and Share by Manufactures (2015 and 2016)

3 USA EPILEPSY DRUGS (VOLUME AND VALUE) BY TYPE

3.1 USA Epilepsy Drugs Sales and Market Share by Type (2011-2021)
3.2 USA Epilepsy Drugs Revenue and Market Share by Type (2011-2021)

4 USA EPILEPSY DRUGS (VOLUME) BY APPLICATION

5 USA EPILEPSY DRUGS MANUFACTURERS ANALYSIS

5.1 Eisai
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Epilepsy Drugs Product Type and Technology
    5.1.2.1 First-generation Anti-epileptic Drugs
    5.1.2.2 Second-generation Anti-epileptic Drugs
  5.1.3 Epilepsy Drugs Sales, Revenue, Price of Eisai (2015 and 2016)
5.2 GSK
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Pharmaceuticals Product Type and Technology
    5.2.2.1 First-generation Anti-epileptic Drugs
    5.2.2.2 Second-generation Anti-epileptic Drugs
  5.2.3 Pharmaceuticals Sales, Revenue, Price of GSK (2015 and 2016)
5.3 Pfizer
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 Pfizer Product Type and Technology
    5.3.2.1 First-generation Anti-epileptic Drugs
    5.3.2.2 Second-generation Anti-epileptic Drugs
  5.3.3 Pfizer Sales, Revenue, Price of Pfizer (2015 and 2016)
5.4 UCB
  5.4.1 Company Basic Information,Manufacturing Base and Competitors
  5.4.2 Aurobindo Pharma Product Type and Technology
    5.4.2.1 First-generation Anti-epileptic Drugs
    5.4.2.2 Second-generation Anti-epileptic Drugs
  5.4.3 UCB Sales, Revenue, Price of UCB (2015 and 2016)
5.5 AbbVie
  5.5.1 Company Basic Information,Manufacturing Base and Competitors
  5.5.2 AbbVie Product Type and Technology
    5.5.2.1 First-generation Anti-epileptic Drugs
    5.5.2.2 Second-generation Anti-epileptic Drugs
  5.5.3 AbbVie Sales, Revenue, Price of AbbVie (2015 and 2016)
5.6 Acorda Therapeutics
  5.6.1 Company Basic Information,Manufacturing Base and Competitors
  5.6.2 Acorda Therapeutics Product Type and Technology
    5.6.2.1 First-generation Anti-epileptic Drugs
    5.6.2.2 Second-generation Anti-epileptic Drugs
  5.6.3 Acorda Therapeutics Sales, Revenue, Price of Acorda Therapeutics (2015 and 2016)
5.7 Alexza Pharmaceuticals
  5.7.1 Company Basic Information,Manufacturing Base and Competitors
  5.7.2 Alexza Pharmaceuticals Product Type and Technology
    5.7.2.1 First-generation Anti-epileptic Drugs
    5.7.2.2 Second-generation Anti-epileptic Drugs
  5.7.3 Alexza Pharmaceuticals Sales, Revenue, Price of Alexza Pharmaceuticals (2015 and 2016)
5.8 Aprecia Pharmaceuticals
  5.8.1 Company Basic Information,Manufacturing Base and Competitors
  5.8.2 Aprecia Pharmaceuticals Product Type and Technology
    5.8.2.1 First-generation Anti-epileptic Drugs
    5.8.2.2 Second-generation Anti-epileptic Drugs
  5.8.3 Aprecia Pharmaceuticals Sales, Revenue, Price of Aprecia Pharmaceuticals (2015 and 2016)
5.9 Aurobindo Pharma
  5.9.1 Company Basic Information,Manufacturing Base and Competitors
  5.9.2 Aurobindo Pharma Product Type and Technology
    5.9.2.1 First-generation Anti-epileptic Drugs
    5.9.2.2 Second-generation Anti-epileptic Drugs
  5.9.3 Aurobindo Pharma Sales, Revenue, Price of Aurobindo Pharma (2015 and 2016)
5.10 Biscayne Pharmaceuticals
  5.10.1 Company Basic Information,Manufacturing Base and Competitors
  5.10.2 Biscayne Pharmaceuticals Product Type and Technology
    5.10.2.1 First-generation Anti-epileptic Drugs
    5.10.2.2 Second-generation Anti-epileptic Drugs
  5.10.3 Biscayne Pharmaceuticals Sales, Revenue, Price of Biscayne Pharmaceuticals (2015 and 2016)
5.11 CURx Pharmaceuticals
5.12 Dainippon Sumitomo Pharma
5.13 D-Pharm
5.14 F. Hoffmann-La Roche
5.15 Grupo Ferrer Internacional
5.16 GW Pharmaceuticals
5.17 Insero Health
5.18 INSYS Therapeutics
5.19 Janssen Pharmaceuticals
5.20 Ligand Pharmaceuticals
5.21 H. Lundbeck
5.22 MarcoPolo Pharmaceuticals
5.23 Marinus Pharmaceuticals
5.24 Meda
5.25 Neurelis
5.26 Nobelpharma
5.27 Novartis
5.28 Orphelia Pharma
5.29 SAGE Therapeutics
5.30 SciFlour

6 EPILEPSY DRUGS TECHNOLOGY AND DEVELOPMENT TREND

6.1 Epilepsy Drugs Technology Analysis
6.2 Epilepsy Drugs Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Epilepsy Drugs
Table Classification of Epilepsy Drugs
Figure USA Sales Market Share of Epilepsy Drugs by Type in 2015
Figure First-generation Anti-epileptic Drugs Picture
Figure Second-generation Anti-epileptic Drugs Picture
Figure Third-generation Anti-epileptic Drugs Picture
Table Applications of Epilepsy Drugs
Figure USA Sales Market Share of Epilepsy Drugs by Application in 2015
Table USA Epilepsy Drugs Sales, Revenue and Price (2011-2021)
Figure USA Epilepsy Drugs Sales and Growth Rate (2011-2021)
Figure USA Epilepsy Drugs Revenue and Growth Rate (2011-2021)
Table USA Epilepsy Drugs Sales of Key Manufacturers (2015 and 2016)
Table USA Epilepsy Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Epilepsy Drugs Sales Share by Manufacturers
Figure 2016 Epilepsy Drugs Sales Share by Manufacturers
Table USA Epilepsy Drugs Revenue by Manufacturers (2015 and 2016)
Table USA Epilepsy Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Epilepsy Drugs Revenue Share by Manufacturers
Table 2016 USA Epilepsy Drugs Revenue Share by Manufacturers
Table USA Epilepsy Drugs Sales and Market Share by Type (2011-2021)
Table USA Epilepsy Drugs Sales Share by Type (2011-2021)
Figure Sales Market Share of Epilepsy Drugs by Type (2011-2021)
Figure USA Epilepsy Drugs Sales Growth Rate by Type (2011-2021)
Table USA Epilepsy Drugs Revenue and Market Share by Type (2011-2021)
Table USA Epilepsy Drugs Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Epilepsy Drugs by Type (2011-2021)
Figure USA Epilepsy Drugs Revenue Growth Rate by Type (2011-2021)
Table USA Epilepsy Drugs Sales and Market Share by Application (2011-2021)
Table USA Epilepsy Drugs Sales Share by Application (2011-2021)
Figure Sales Market Share of Epilepsy Drugs by Application (2011-2021)
Figure USA Epilepsy Drugs Sales Growth Rate by Application (2011-2021)
Table Eisai Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Eisai (2015 and 2016)
Table GSK Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of GSK (2015 and 2016)
Table Pfizer Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Pfizer (2015 and 2016)
Table UCB Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of UCB (2015 and 2016)
Table AbbVie Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of AbbVie (2015 and 2016)
Table Acorda Therapeutics Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Acorda Therapeutics (2015 and 2016)
Table Alexza Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Alexza Pharmaceuticals (2015 and 2016)
Table Aprecia Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Aprecia Pharmaceuticals (2015 and 2016)
Table Aurobindo Pharma Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Aurobindo Pharma (2015 and 2016)
Table Biscayne Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Biscayne Pharmaceuticals (2015 and 2016)
Table CURx Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of CURx Pharmaceuticals (2015 and 2016)
Table Dainippon Sumitomo Pharma Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Dainippon Sumitomo Pharma (2015 and 2016)
Table D-Pharm Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of D-Pharm (2015 and 2016)
Table F. Hoffmann-La Roche Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of F. Hoffmann-La Roche (2015 and 2016)
Table Grupo Ferrer Internacional Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Grupo Ferrer Internacional (2015 and 2016)
Table GW Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of GW Pharmaceuticals (2015 and 2016)
Table Insero Health Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Insero Health (2015 and 2016)
Table INSYS Therapeutics Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of INSYS Therapeutics (2015 and 2016)
Table Janssen Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Janssen Pharmaceuticals (2015 and 2016)
Table Ligand Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Ligand Pharmaceuticals (2015 and 2016)
Table H. Lundbeck Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of H. Lundbeck (2015 and 2016)
Table MarcoPolo Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of MarcoPolo Pharmaceuticals (2015 and 2016)
Table Marinus Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Marinus Pharmaceuticals (2015 and 2016)
Table Meda Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Meda (2015 and 2016)
Table Neurelis Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Neurelis (2015 and 2016)
Table Nobelpharma Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Nobelpharma (2015 and 2016)
Table Novartis Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Novartis (2015 and 2016)
Table Orphelia Pharma Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Orphelia Pharma (2015 and 2016)
Table SAGE Therapeutics Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of SAGE Therapeutics (2015 and 2016)
Table SciFlour Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of SciFlour (2015 and 2016 )